Onyx Spurs Pfizer Talk With Cancer Drug as Patent Cure

Onyx Spurs Pfizer Talk With Cancer Drug as Patent Cure

Onyx Pharmaceuticals via Bloomberg

Onyx, which already sells a kidney-cancer treatment named Nexavar, seen here, may get U.S. approval for carfilzomib as early as March, helping it double sales within five years, analysts’ estimates show.